SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (373)10/31/2000 12:09:54 PM
From: tom pope  Respond to of 1833
 
Does anybody know whether under current securities law there is an obligation to provide such info?



To: scaram(o)uche who wrote (373)10/31/2000 1:21:27 PM
From: Tomato  Read Replies (1) | Respond to of 1833
 
Phone number for Glass and other stuff:

quicken.excite.com

Don't the SEC filings indicate that KDUS owns 30% of Axiom, or has something changed since then?



To: scaram(o)uche who wrote (373)10/31/2000 4:41:48 PM
From: Geigartt  Read Replies (1) | Respond to of 1833
 
Richard:

I'm confused. You suggest in one post the % ownership of Axiom is material info and we should put Glass on notice that we want it (which implies we have it); later you say, why complain, they have given us all material information.

I'll be glad to add my inquiry.

The number I have is 212-702-4315

Steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News